Apoptosis and cancer: mutations within caspase genes
Open accessThe DOI matches its Crossref record; 178 of the 178 references it cites were found in a registry or an index.
Abstract
The inactivation of programmed cell death has profound effects not only on the development but also on the overall integrity of multicellular organisms. Beside developmental abnormalities, it may lead to tumorigenesis, autoimmunity, and other serious health problems. Deregulated apoptosis may also be the leading cause of cancer therapy chemoresistance. Caspase family of cysteinyl-proteases plays the key role in the initiation and execution of programmed cell death. This review gives an overview of the role of caspases, their natural modulators like IAPs, FLIPs, and Smac/Diablo in apoptosis and upon inactivation, and also in cancer development. Besides describing the basic mechanisms governing programmed cell death, a large part of this review is dedicated to previous studies that were focused on screening tumours for mutations within caspase genes as well as their regulators. The last part of this review discusses several emerging treatments that involve modulation of caspases and their regulators. Thus, we also highlight caspase cascade modulating experimental anticancer drugs like cFLIP-antagonist CDDO-Me; cIAP1 antagonists OSU-03012 and ME-BS; and XIAP small molecule antagonists 1396–11, 1396–12, 1396–28, triptolide, AEG35156, survivin/Hsp90 antagonist shephedrin, and some of the direct activators of procaspase-3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Thornberry, N. A., & Lazebnik, Y. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,887
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Emerging roles of caspase-3 in apoptosis
Porter, A. G., & Jänicke, R. U. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400476 · Cited by 3,855
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β
Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A., & Yuan, J. (2000) · Nature · doi:10.1038/47513 · Cited by 3,256
Zou, H., Henzel, W. J., Liu, X., Lutschg, A., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80501-2 · Cited by 3,145
Inhibition of death receptor signals by cellular FLIP
Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J.-L., Schröter, M., Burns, K., Mattmann, C., et al. (1997) · Nature · doi:10.1038/40657 · Cited by 2,563
Cited by
Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis
Ouyang, L., Shi, Z., Zhao, S., Wang, F. ‐., Zhou, T. ‐., Liu, B., & Bao, J. ‐. (2012) · Cell Proliferation · doi:10.1111/j.1365-2184.2012.00845.x · Cited by 1,452
Autophagy and apoptosis dysfunction in neurodegenerative disorders
Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S. R., Jangamreddy, J. R., Mehrpour, M., Christoffersson, J., Chaabane, W., Moghadam, A. R., Kashani, H. H., et al. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.10.004 · Cited by 1,039
“Proteolytic enzymes with specificity toward aspartate, and with cysteine in their active center, called caspases, are well conserved from early nematodes to the modern vertebrates and are the main propagators of apoptotic program at the cellular level (Ghavami et al., 2009b; Stroh et al., 2002).”
Self-citationRole of Bcl-2 family proteins and caspases in the regulation of apoptosis
Ola, M. S., Nawaz, M., & Ahsan, H. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0709-x · Cited by 920
Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics
Jan, R., & Chaudhry, G.-E.-S. (2019) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2019.024 · Cited by 899
The caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer
Jiang, M., Qi, L., Li, L., & Li, Y. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00349-0 · Cited by 686
MOMP, cell suicide as a BCL-2 family business
Kalkavan, H., & Green, D. R. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.179 · Cited by 664
Major apoptotic mechanisms and genes involved in apoptosis
Kiraz, Y., Adan, A., Kartal Yandim, M., & Baran, Y. (2016) · Tumor Biology · doi:10.1007/s13277-016-5035-9 · Cited by 582
Li, Y., Liu, Y., Fu, Y., Wei, T., Le Guyader, L., Gao, G., Liu, R.-S., Chang, Y.-Z., & Chen, C. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.091 · Cited by 509
Necrotic, apoptotic and autophagic cell fates triggered by nanoparticles
Mohammadinejad, R., Moosavi, M. A., Tavakol, S., Vardar, D. Ö., Hosseini, A., Rahmati, M., Dini, L., Hussain, S., Mandegary, A., & Klionsky, D. J. (2019) · Autophagy · doi:10.1080/15548627.2018.1509171 · Cited by 453
Olsson, M., & Zhivotovsky, B. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.30 · Cited by 415
Molecular aspects of cancer cell resistance to chemotherapy
Rebucci, M., & Michiels, C. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.02.017 · Cited by 407
Lewis, N. E., Liu, X., Li, Y., Nagarajan, H., Yerganian, G., O'Brien, E., Bordbar, A., Roth, A. M., Rosenbloom, J., Bian, C., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2624 · Cited by 380
Hombach-Klonisch, S., Mehrpour, M., Shojaei, S., Harlos, C., Pitz, M., Hamai, A., Siemianowicz, K., Likus, W., Wiechec, E., Toyota, B. D., et al. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.017 · Cited by 292
Self-citationKim, H., George, E., Ragland, R. L., Rafail, S., Zhang, R., Krepler, C., Morgan, M. A., Herlyn, M., Brown, E. J., & Simpkins, F. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2273 · Cited by 291
Chaabane, W., User, S. D., El-Gazzah, M., Jaksik, R., Sajjadi, E., Rzeszowska-Wolny, J., & Łos, M. J. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0205-y · Cited by 282
Adiponectin receptor signalling in the brain
Thundyil, J., Pavlovski, D., Sobey, C. G., & Arumugam, T. V. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01560.x · Cited by 280
A Time to Kill: Targeting Apoptosis in Cancer
Koff, J., Ramachandiran, S., & Bernal-Mizrachi, L. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16022942 · Cited by 279
Yang, J., Liu, X.-X., Fan, H., Tang, Q., Shou, Z.-X., Zuo, D.-M., Zou, Z., Xu, M., Chen, Q.-Y., Peng, Y., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0140551 · Cited by 277
Betulin and its derivatives as novel compounds with different pharmacological effects
Amiri, S., Dastghaib, S., Ahmadi, M., Mehrbod, P., Khadem, F., Behrouj, H., Aghanoori, M.-R., Machaj, F., Ghamsari, M., Rosik, J., et al. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.06.008 · Cited by 272
Self-citationHenry, C. M., & Martin, S. J. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.01.022 · Cited by 267
Ghavami, S., Eshragi, M., Ande, S. R., Chazin, W. J., Klonisch, T., Halayko, A. J., Mcneill, K. D., Hashemi, M., Kerkhoff, C., & Los, M. (2010) · Cell Research · doi:10.1038/cr.2009.129 · Cited by 267
Self-citationMehrbod, P., Ande, S. R., Alizadeh, J., Rahimizadeh, S., Shariati, A., Malek, H., Hashemi, M., Glover, K. K. M., Sher, A. A., Coombs, K. M., et al. (2019) · Virulence · doi:10.1080/21505594.2019.1605803 · Cited by 242
“These include TNFR1, Fast/Apo/CD95 (TNFRSF6), DR3 (TNFRSF25), DR4 (TNFRSF10A), DR5 (TNFRSF10B) and DR6 (TNFRSF21) [39,40].”
BackgroundSelf-citationNitric oxide in cancer metastasis
Cheng, H., Wang, L., Mollica, M., Re, A. T., Wu, S., & Zuo, L. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.07.014 · Cited by 182
“This resistance largely contributes to poor prognosis by affecting tissue homeostasis and causing failure of treatments.[38, 39] Through the use of a series of adenoviral vectors that expressed different levels of iNOS activity, Xie et al.”
BackgroundLiu, D., Jin, F., Shu, G., Xu, X., Qi, J., Kang, X., Yu, H., Lu, K., Jiang, S., Han, F., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.04.034 · Cited by 169
Khan, R., & Sultana, S. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.03.009 · Cited by 161
“Caspases are the cysteinedependent enzymes and are activated by oxidative stress [79].”
BackgroundAntitumor Peptides from Marine Organisms
Zheng, L.-H., Wang, Y.-J., Sheng, J., Wang, F., Zheng, Y., Lin, X.-K., & Sun, M. (2011) · Marine Drugs · doi:10.3390/md9101840 · Cited by 146
“Identification of caspases activators becomes another approach for the discovery of novel anticancer agents because caspases are involved in intrinsic and extrinsic apoptosis pathways [23,24].”
BackgroundGold from the sea: Marine compounds as inhibitors of the hallmarks of cancer
Schumacher, M., Kelkel, M., Dicato, M., & Diederich, M. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.02.002 · Cited by 138
“Bid and Bim, potentiate the pro-apoptotic activity of Bax and Bak (Ghavami et al., 2009).”
BackgroundHe, W., Wang, Q., Srinivasan, B., Xu, J., Padilla, M. T., Li, Z., Wang, X., Liu, Y., Gou, X., Shen, H.-M., et al. (2014) · Oncogene · doi:10.1038/onc.2013.256 · Cited by 124
Li, X., Zhu, F., Jiang, J., Sun, C., Wang, X., Shen, M., Tian, R., Shi, C., Xu, M., Peng, F., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.11.026 · Cited by 116
Apoptosis: molecular mechanisms and pathogenicity
Rastogi, R. P., R., & Sinha, R. P. (2010) · Technische Universität Dortmund · doi:10.17877/de290r-8930 · Cited by 106
“…acid) are aspartate-directed cysteine proteases that play a key role in the initiation and execution of apoptosis or PCD, necrosis and inflammation, failure of which may cause tumor development and several autoimmune diseases (Danial & Korsmeyer, 2004; Ghavami et al., 2009; Green et al., 2009).”
Hudson, R. S., Yi, M., Esposito, D., Glynn, S. A., Starks, A. M., Yang, Y., Schetter, A. J., Watkins, S. K., Hurwitz, A. A., Dorsey, T. H., et al. (2013) · Oncogene · doi:10.1038/onc.2012.424 · Cited by 98
Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy
Yi, M., Zhang, L., Liu, Y., Livingston, M. J., Chen, J.-K., Nahman, N. S., Liu, F., & Dong, Z. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00114.2017 · Cited by 86
“Biochemically, we analyzed the proteolytic processing of caspase-3 into active fragments, a hallmark of apoptosis (4).”
Takla, F. N., Bayoumi, W. A., El-Messery, S. M., & Nasr, M. N. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-40232-3 · Cited by 21
“40 .”
ZHONG, J.-M., WU, S.-Y., BAI, J., GUO, Q., TAO, J., CHEN, H., ZHAO, N.-W., ZHAO, Z., & FU, H. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.669 · Cited by 14
Metadata
- Authors
- Ghavami, S., Hashemi, M., Ande, S. R., Yeganeh, B., Xiao, W., Eshraghi, M., Bus, C. J., Kadkhoda, K., Wiechec, E., Halayko, A. J., & Los, M.
- Venue
- Journal of Medical Genetics
- Publisher
- BMJ
- Published
- 2009-06-07
- Volume
- 46
- Issue
- 8
- Pages
- 497-510
- ISSN
- 0022-2593 (ISSN-L)
- 1468-6244
- OpenAlex
- W2012141576
- Cited by
- 713
- References
- 178
- FWCI
- 13.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.